These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16433129)

  • 21. Diagnostic and prognostic markers in gliomas - an update.
    Ma R; de Pennington N; Hofer M; Blesing C; Stacey R
    Br J Neurosurg; 2013 Jun; 27(3):311-5. PubMed ID: 23278177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The First Step in a Long-Run-Celebrating the announcement of "Guideline for the management of CNS gliomas in China"].
    Zhou LF
    Zhonghua Yi Xue Za Zhi; 2013 Aug; 93(31):2417. PubMed ID: 24300261
    [No Abstract]   [Full Text] [Related]  

  • 23. [Comparative structural study of the glial blastomas of the central nervous system].
    Rodríguez A; Cejas H
    Rev Fac Cien Med Univ Nac Cordoba; 1999; 56(1):43-64. PubMed ID: 10668265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 2007 World Health Organization classification of tumours of the central nervous system.
    Thurnher MM
    Cancer Imaging; 2009 Oct; 9 Spec No A(Special issue A):S1-3. PubMed ID: 19965289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Central nervous system tumors.
    Packer RJ; Macdonald T; Vezina G
    Hematol Oncol Clin North Am; 2010 Feb; 24(1):87-108. PubMed ID: 20113897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Central nervous system tumors.
    Packer RJ; MacDonald T; Vezina G
    Pediatr Clin North Am; 2008 Feb; 55(1):121-45, xi. PubMed ID: 18242318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinct methylation profiles of glioma subtypes.
    Uhlmann K; Rohde K; Zeller C; Szymas J; Vogel S; Marczinek K; Thiel G; Nürnberg P; Laird PW
    Int J Cancer; 2003 Aug; 106(1):52-9. PubMed ID: 12794756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Revised WHO Classification of Tumours of the Central Nervous System:Summary of the Revision and Perspective].
    Komori T; Sasaki H; Yoshida K
    No Shinkei Geka; 2016 Aug; 44(8):625-35. PubMed ID: 27506840
    [No Abstract]   [Full Text] [Related]  

  • 29. Physiologic and metabolic magnetic resonance imaging in gliomas.
    Cao Y; Sundgren PC; Tsien CI; Chenevert TT; Junck L
    J Clin Oncol; 2006 Mar; 24(8):1228-35. PubMed ID: 16525177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuropathological biopsy diagnoses in clinical practice: how thorough and reproducible are they?
    Ojeda VJ; al Moutaery KR
    Pathology; 1998 Aug; 30(3):328-9. PubMed ID: 9770206
    [No Abstract]   [Full Text] [Related]  

  • 31. The expanding family of glioneuronal tumors.
    Allende DS; Prayson RA
    Adv Anat Pathol; 2009 Jan; 16(1):33-9. PubMed ID: 19098465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical studies in diagnosis of the uncommon cases of tumours of the central nervous system.
    Taraszewska A; Matyja E
    Folia Histochem Cytobiol; 2002; 40(2):207-8. PubMed ID: 12056648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Focus on central nervous system neoplasia.
    Louis DN; Pomeroy SL; Cairncross JG
    Cancer Cell; 2002 Mar; 1(2):125-8. PubMed ID: 12086870
    [No Abstract]   [Full Text] [Related]  

  • 34. Teratomas in central nervous system: a clinico-morphological study with review of literature.
    Agrawal M; Uppin MS; Patibandla MR; Bhattacharjee S; Panigrahi MK; Saradhi V; Rani JY; Purohit AK; Challa S
    Neurol India; 2010; 58(6):841-6. PubMed ID: 21150046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Schwannomas of central nervous system].
    Kajiwara Y; Sugiyama K; Kurisu K
    Nihon Rinsho; 2005 Sep; 63 Suppl 9():139-44. PubMed ID: 16201514
    [No Abstract]   [Full Text] [Related]  

  • 36. Diffusion tensor imaging of intraaxial tumors at the cervicomedullary and pontomedullary junctions. Report of two cases.
    Phillips NS; Sanford RA; Helton KJ; Boop FA; Zou P; Tekautz T; Gajjar A; Ogg RJ
    J Neurosurg; 2005 Dec; 103(6 Suppl):557-62. PubMed ID: 16383256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediagnostic presentations of glioma in primary care: a case-control study.
    Peeters MC; Dirven L; Koekkoek JA; Numans ME; Taphoorn MJ
    CNS Oncol; 2019 Nov; 8(3):CNS44. PubMed ID: 31674205
    [No Abstract]   [Full Text] [Related]  

  • 38. Building diagnoses with four layers: WHO 2016 classification of CNS tumors.
    Bielle F
    Rev Neurol (Paris); 2016; 172(4-5):253-5. PubMed ID: 27210026
    [No Abstract]   [Full Text] [Related]  

  • 39. Template for Reporting Results of Biomarker Testing of Specimens From Patients With Tumors of the Central Nervous System.
    Brat DJ; Cagle PT; Dillon DA; Hattab EM; McLendon RE; Miller MA; Buckner JC;
    Arch Pathol Lab Med; 2015 Sep; 139(9):1087-93. PubMed ID: 25642959
    [No Abstract]   [Full Text] [Related]  

  • 40. Optic chiasmatic-hypothalamic gliomas: is tissue diagnosis essential?
    Bommakanti K; Panigrahi M; Yarlagadda R; Sundaram C; Uppin MS; Purohit AK
    Neurol India; 2010; 58(6):833-40. PubMed ID: 21150045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.